«Grindeks»' Main fields of action are research, development, manufacturing and sales of original products, generics and active pharmaceutical ingredients. «Grindeks» Group consists of 4 subsidiary companies and representative offices in 11 countries.
Outsourcing: do more with less!
Some time ago, it was believed that the pharmaceutical industry would not be affected by an economic crisis. However, this is not longer the case. The deepening of the global economic crisis has significantly reduced end consumer purchasing power and is leading to increased competition between producers and the price of goods or services and effectively reducing their costs is more important than ever. This is driving all market players, including pharmaceutical companies, to find ways to optimise internal company costs and improve efficiency. One option or solution for improving business is to concentrate financial and human resources on the company's long-term, strategic processes, for example R&D, and to outsource less important, non-core processes to companies specialised in effectively providing a specific service.
Millions of euros for new modern laboratory
New laboratory of JSC «Grindeks» for scale-up procedures and industrial analytics has received one of the most significant amounts of EU fundings that has ever been granted to business companies in Latvia.